SAN DIEGO, Nov. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBDCapitalGroup (“CCG” or the “Company”), a cannabidiol (CBD) nutraceuticals investment...
The completion of our second acquisition further demonstrates the ability of the CCG team to consistently add acquisitive CBD revenue at below-market multiples, while at the same time continue to organically and profitably grow our portfolio revenue.